Amended in Senate March 15, 2016

Senate BillNo. 938


Introduced by Senator Jackson

February 2, 2016


An act to amend Section 2356.5 of the Probate Code, relating tobegin delete protective proceedings.end deletebegin insert conservatorships.end insert

LEGISLATIVE COUNSEL’S DIGEST

SB 938, as amended, Jackson. begin deleteProtective proceedings: conservator authorizations. end deletebegin insertConservatorships: psyend insertbegin insertchend insertbegin insertotropic drugs.end insert

Existing law authorizes a conservator to place a conservatee in a secured perimeter residential care facility, as specified, or to administer certain prescribed medications upon a court’s finding that among other things, the conservatee has dementia and a functional impairment. Existing law requires certain findings to be made by the court for each type of authority sought by the conservator and requires a petition for authority to be supported by a declaration of a licensed physician or psychologist, as specified, regarding these findings.

This bill would replace references to the term dementia in these provisions with major neurocognitive disorders (MNCDs).begin delete The bill would prohibit the placement of a conservatee in an acute psychiatric hospital and psychiatric health facility, as specified.end delete The bill would require petitions requesting the authority to administer certain prescribed medications to be supported by a declaration of abegin delete licensed physician, psychiatrist,end deletebegin insert physicianend insert or psychologist that includes specified informationbegin insert,end insert including, among other things,begin delete the reasons for the request, information regarding the rationale for the proposed medication, and information regarding the conservatee’s overall mental health assessment and treatment plan.end deletebegin insert the recommended course of medication, the expected effects of the recommended medication on the conservatee’s overall mental health and treatment plan, including how the medication is expected to improve the conservatee’s symptoms, and a description of the potential side effects of the recommended medication.end insert The bill would require the Judicial Council, on or before July 1, 2017, to adopt rules of court and develop appropriate forms for the implementation of these provisions, as specified. The bill would make additional findings and declarations of the Legislature.

Vote: majority. Appropriation: no. Fiscal committee: yes. State-mandated local program: no.

The people of the State of California do enact as follows:

P2    1

SECTION 1.  

Section 2356.5 of the Probate Code is amended
2to read:

3

2356.5.  

(a) The Legislature hereby finds and declares:

4(1) That conservatees with majorbegin insert or mildend insert neurocognitive
5disorders (MNCDs), as defined in the last published edition of the
6“Diagnostic and Statistical Manual of Mental Disorders,” should
7have a conservatorship to serve their unique and special needs.

8(2) Common forms of MNCDs are known as Alzheimer’s
9disease, vascular dementia, dementia with Lewy bodies, Parkinson
10 dementia, frontotemporal dementia, and mixed dementia.

11(3) That, by adding powers to the probate conservatorship for
12conservatees with MNCDs, their unique and special needs can be
13begin delete met. This will reduce costs to the conservatee and the family of
14the conservatee, reduce costly administration by state and county
15government, and safeguard the basic dignity and rights of the
16conservatee.end delete
begin insert met, and the basic dignity and rights of the
17conservatee can be safeguarded.end insert

18(4) Psychotropic medications or psychotropic drugs are those
19medications administered for the purpose of affecting the central
20nervous system to treat psychiatric disorders or illnesses.begin delete These
21medications include, but are not limited to, anxiolytic agents,
22antidepressants, mood stabilizers, antipsychotic medications,
23anti-Parkinson agents, hypnotics, medications for dementia, and
24psychostimulants.end delete

25(5) Psychotropic medications are often misused for people with
26MNCDs to control behavior that conveys pain, distress, or
27begin delete discomfort.end deletebegin insert discomfort and the administration of psychotropic
P3    1medications has been and can be abused by those who prescribe
2and administer these medications.end insert

3(6) Since 2005, the federal Food and Drug Administration has
4required the packaging of all antipsychotic medications, which
5fall under a class of psychotropic medication, to contain a black
6box warning label that the medication significantly increases the
7risk of death for elderly people with MNCDs.

8(7) Recent studies have shown that, in many instances,
9psychotropic drugs are outperformed by placebos and can actually
10worsen the cognitive ability of a person with an MNCD.

begin delete

11(8) The administration of psychotropic medications has been,
12and can be, abused by caregivers.

13(9)

end delete

14begin insert(8)end insert Therefore, granting powers to a conservator to authorize
15these medications for the treatment of an MNCD requires the
16protections specified in this section.

17(b) Notwithstanding any other law, a conservator may authorize
18the placement of a conservatee in a secured perimeter residential
19care facility for the elderly operated pursuant to Section 1569.698
20of the Health and Safety Code, and which has a care plan that
21meets the requirements of Section 87705 of Title 22 of the
22California Code of Regulations, upon a court’s finding, by clear
23and convincing evidence, of all of the following:

24(1) The conservatee has an MNCD as defined in the last
25published edition of the “Diagnostic and Statistical Manual of
26Mental Disorders.”

27(2) The conservatee lacks the capacity to give informed consent
28to this placement and has at least one mental function deficit
29pursuant to subdivision (a) of Section 811, and this deficit
30significantly impairs the person’s ability to understand and
31appreciate the consequences of his or her actions pursuant to
32subdivision (b) of Section 811.

33(3) The conservatee needsbegin delete or would benefit fromend delete a restricted
34and secure environment, as demonstrated by evidence presented
35by the physician or psychologist referred to in paragraph (3) of
36subdivisionbegin delete (f).end deletebegin insert (eend insertbegin insert).end insert

37(4) The court finds that the proposed placement in a locked
38facility is the least restrictive placement appropriate to the needs
39of the conservatee.

P4    1(c) Notwithstanding any other law, a conservator of a person
2may authorize the administration ofbegin insert psychotropicend insert medications
3begin delete appropriate for the care and treatment ofend deletebegin insert to a conservatee withend insert an
4MNCD, upon a court’s finding, by clear and convincing evidence,
5of all of the following:

6(1) The conservatee has an MNCD, as defined in the last
7published edition of the “Diagnostic and Statistical Manual of
8Mental Disorders.”

9(2) The conservatee lacks the capacity to give informed consent
10to the administration ofbegin insert psychotropicend insert medicationsbegin delete appropriate to
11the care of theend delete
begin insert for the treatment of anend insert MNCD, and has at least one
12mental function deficit pursuant to subdivision (a) of Section 811,
13and this deficit or deficits significantly impairs the person’s ability
14to understand and appreciate the consequences of his or her actions
15pursuant to subdivision (b) of Section 811.

16(3) The conservatee needs appropriate medication as
17demonstrated by evidence presented by the begin delete licensed physician,
18psychiatrist,end delete
begin insert physicianend insert or psychologist referred to in paragraphbegin delete (4)end delete
19begin insert (3)end insert of subdivisionbegin delete (f).end deletebegin insert (e).end insert

20(d) Pursuant to subdivision (b) of Section 2355, in the case of
21a person who is an adherent of a religion whose tenets and practices
22call for a reliance on prayer alone for healing, the treatment
23required by the conservator under subdivision (c) shall be by an
24accredited practitioner of that religion in lieu of the administration
25of medications.

begin delete

26(e) A conservatee who is to be placed in a facility pursuant to
27this section shall not be placed in a mental health rehabilitation
28center as described in Section 5675 of the Welfare and Institutions
29Code, an institution for mental disease as described in Section
305900 of the Welfare and Institutions Code, an acute psychiatric
31 hospital as described in subdivision (b) of Section 1250 of the
32Health and Safety Code, or a psychiatric health facility as described
33in subdivision (a) of Section 1250.2 of the Health and Safety Code.

34(f)

end delete

35begin insert(e)end insert A petition for authority to act under this section is governed
36by Section 2357, except:

37(1) The conservatee shall be represented by an attorney pursuant
38to Chapter 4 (commencing with Section 1470) of Part 1. Upon
39granting or denying authority to a conservator under this section,
40the court shall discharge the attorney or order the continuation of
P5    1the legal representation, consistent with the standard set forth in
2subdivision (a) of Section 1470.

3(2) The conservatee shall be produced at the hearing, unless
4excused pursuant to Section 1893.

5(3) The petition requesting authority under subdivision (b)begin insert or
6(c)end insert
shall be supported by a declaration of abegin delete licensedend delete physician, or
7abegin delete licensedend delete psychologist within the scope of his or her licensure,
8regarding each of the findings required to be made under this
9section for any power requested, except that the psychologist has
10at least two years of experience in diagnosing MNCDs.begin insert The
11supporting declaration for a petition requesting authority under
12subdivision (c) shall also include all of the following:end insert

begin delete

13(4) The petition requesting authority under subdivision (c) shall
14be supported by a declaration of the licensed physician,
15psychiatrist, or psychologist, and provide all of the following:

end delete
begin delete

16(A) The reasons for the request.

end delete
begin delete

17(B)

end delete

18begin insert(A)end insert A description of the conservatee’s diagnosis and behavior.

begin insert

19(B) The recommended course of medication.

end insert
begin insert

20(C) A description of the pharmacological and
21nonpharmacological treatments and medications that have been
22previously used or proposed, the less invasive treatments or
23medications used or proposed, and why these treatments or
24medications have not been or would not be effective in treating
25the conservatee’s symptoms.

end insert
begin delete

26(C)

end delete

27begin insert(D)end insert The expectedbegin delete results of the medication.end deletebegin insert end insertbegin inserteffects of the
28recommended medication on the conservatee’s overall mental
29health and treatment plan, including how the medication is
30expected to improve the conservatee’s symptoms.end insert

begin delete

31(D)

end delete

32begin insert(Eend insertbegin insert)end insert A description ofbegin delete anyend deletebegin insert the potentialend insert side effects of the
33begin insert recommendedend insert medication.

begin delete

34(E)

end delete

35begin insert(F)end insert Whether the conservatee and his or her attorney have had
36an opportunity to provide input on the begin delete medications being
37 prescribed.end delete
begin insert recommended medications.end insert

begin delete

38(F) Information regarding the conservatee’s overall mental
39health assessment and treatment plan.

end delete
begin delete

P6    1(G) Information regarding the rationale for the proposed
2medication, provided in the context of past and current treatment
3efforts, including, but not limited to, information on other
4pharmacological and nonpharmacological treatments that have
5been utilized and the conservatee’s response to those treatments,
6a discussion of symptoms not alleviated or ameliorated by other
7current or past treatment efforts, and an explanation of how the
8psychotropic medication being prescribed is expected to improve
9the conservatee’s symptoms.

end delete
begin delete

10(5)

end delete

11begin insert(4)end insert On or before July 1, 2017, the Judicial Council shall adopt
12rules of court and develop appropriate forms for the implementation
13of this section, and shall provide guidance to the court on how to
14evaluate the request for authorization, including how to proceed
15if information, otherwise required to be included in a request for
16authorization under this section, is not included in a request for
17authorization submitted to the court.

begin delete

18(6)

end delete

19begin insert(5)end insert The petition may be filed by any of the persons designated
20in Section 1891.

begin delete

21(g)

end delete

22begin insert(f)end insert The court investigator shall annually investigate and report
23to the court every two years pursuant to Sections 1850 and 1851
24if the conservator is authorized to act under this section. In addition
25to the other matters provided in Section 1851, the conservatee shall
26be specifically advised by the investigator that the conservatee has
27the right to object to the conservator’s powers granted under this
28section, and the report shall also include whether powers granted
29under this section are warranted. If the conservatee objects to the
30conservator’s powers granted under this section, or the investigator
31determines that some change in the powers granted under this
32section is warranted, the court shall provide a copy of the report
33to the attorney of record for the conservatee. If no attorney has
34been appointed for the conservatee, one shall be appointed pursuant
35to Chapter 4 (commencing with Section 1470) of Part 1. The
36attorney shall, within 30 days after receiving this report, do one
37of the following:

38(1) File a petition with the court regarding the status of the
39conservatee.

P7    1(2) File a written report with the court stating that the attorney
2has met with the conservatee and determined that the petition
3would be inappropriate.

begin delete

4(h)

end delete

5begin insert(g)end insert A petition to terminate authority granted under this section
6shall be governed by Section 2359.

begin delete

7(i)

end delete

8begin insert(h)end insert Nothing in this section shall be construed to affect a
9conservatorship of the estate of a person who has an MNCD.

begin delete

10(j)

end delete

11begin insert(i)end insert Nothing in this section shall affect the laws that would
12otherwise apply in emergency situations.

begin delete

13(k)

end delete

14begin insert(j)end insert Nothing in this section shall affect current law regarding the
15power of a probate court to fix the residence of a conservatee or
16to authorize medical treatment for any conservatee who has not
17been determined to have an MNCD.



O

    98